최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기핵의학 분자영상 = Nuclear medicine and molecular imaging, v.42 no.4, 2008년, pp.301 - 306
정환정 (전북대학교 의학전문대학원 핵의학교실) , 임석태 (전북대학교 의학전문대학원 핵의학교실) , 윤현조 (전북대학교 의학전문대학원 외과학교실) , 손명희 (전북대학교 의학전문대학원 핵의학교실)
Purpose: Recently, a number of patients needed total thyroidectomy and high dose radioiodine therapy (HD-RAI) get increased more. The aim of this study is to evaluate whether pathological staging (PS) and serum thyroglobulin (sTG) level could replace the diagnostic I-123 scan for the determination o...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics 2004. Cancer J Clin 2004;54:8-29
Hong SW. Radioiodine therapy for differentiated thyroid cancer. Korean J Nucl Med 2000;34:265-75
Lee J, Yun JS, Nam KH, Chung WY, Soh EY, Park CS. Papillary mocrocarcinoma: clinicopathologic characteristics and treatment strategy. J Korean Surg Soc 2007;72:276-82
Shong YK. Treatment of differentiated thyroid cancer. Korean J Nucl Med 2002;36:77-97
Mandel SJ, Shankar LK, Benard F, Yamamoto A, Alavi A. Superority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer. Clin Nucl Med 2001;26:6-9
Gerard SK, Cavalieri RR. I-123 diagnostic thyroid tumor whole-body scanning with imaging at 6, 24, and 48 hours. Clin Nucl Med 2002;27:1-8
Van Nostrand D, Wartofsky L. Radioiodine in the treatment of thyroid cancer. Endocrinol Metab Clin North Am 2007;36: 807-22
Urhan M, Dadparvar S, Mavi A, Houseni M, Chamroonrat W, Alavi A, et al. Iodine-123 as a diagnostic agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement. Eur J Nucl Med Mol Imaging 2007;34:1012-7
Ali N, Sebastian C, Foley RR, Murray I, Canizales AL, Jenkins PJ, et al. The management of differentiated thyroid cancer using I-123 for imaging to assess the need for I-131 therapy. Nucl Med Commun 2006;27:165-9
Cohen JB, Kalinyak JE, McDougall IR. Clinical implications of the differences between diagnostic I-123 and post-therapy I-131 scans. Nucl Med Commun 2004;25:129-34
Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. AJCC cancer staging manual. 6th ed. New York: Springer; 2002. p. 77-87
Handkiewicz-Junak D, Wloch J, Roskosz J, Krajewska J Kropinska A, Pomorski L, et al. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer. J Nucl Med 2007;48:879-88
Lang BH, Lo CY, Chan WF, Lam KY, Wan KY. Staging systems for papillary thyroid carcinoma: a review and comparison. Ann Surg 2007;245:366-78
Pelizzo MR, Boschin IM, Toniato A, Piotto A, Pagetta C, Gross MD, et al. Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients. Clin Nucl Med 2007;32: 440-4
Sosa JA, Udelsman R. Total thyroidectomy for differentiated thyroid cancer. J Surg Oncol 2006;94:701-7
Kjellman P, Zedenius J, Lundell G, Backdahl M, Farnebo LO, Hamberger B, et al. Predictors of outcome in patients with papillary thyroid carcinoma. Eur J Surg Oncol 2006;32:345-52
Lee SJ, Park BS, Kim JS, Park JS. Analyses of cervical lymph node metastases from papillary thyroid cancer. J Korean Surg Soc 2003;64:115-20
Grunwald F, Menzel C, Fimmers R, Zamora PO, Biersack HJ. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer. J Nucl Med 1996;37:1962-4
Kim KS, Ryu JS, Hong SJ, Kim WB, Shong YK. Serum thyroglobulin levels predicting recurrence and distant metastasis after surgery in patients with differentiated thyroid cancer. J Kor Soc Endocrinol 2003;18:153-65
Bachelot A, Cailleux AF, Klain M, Baudin E, Ricard M, Bellon N, et al. Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyoid 2002;12:707-11
Song SH, Park HK, Park YH, Lee JN, Kim JH, Lee YD. Tc-99m tetrofosmin, I-131 whole body scan and thyroglobulin in detecting differentiated thyroid carcinoma metastases. J Korean Surg Soc 2002;63:366-71
Makarewicz J, Adamczewski Z, Knapska-Kucharska M, Lewinski A. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery. Exp Clin Endocrinol Diabetes 2006;114: 485-9
Doi SA, Woodhouse NJ. Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer. Clin Endocrinol(Oxf) 2000;52:765-73
※ AI-Helper는 부적절한 답변을 할 수 있습니다.